FDA appropriations

CFSAN Adverse Events Reporting System would receive $7.6 mil. in FY 2003 funding - including $1.5 mil. for dietary supplements - under Senate Ag Approps bill, which unanimously passed out of committee July 25. CAERS funding represents $2 mil. more than budget request. Measure also provides $2 mil. for botanical research carried out by FDA, U-Miss. center. Generic drugs program would receive $45.3 mil. in funding, a $6.1 mil. increase over FY 2002 level and $1.5 mil. above budget request. Bill calls for $179.2 mil. in funding for CDER, $149.3 mil. for CFSAN and total FDA funding of $1.39 bil., which is $23.4 mil. more than budget request. Full Senate vote has yet to be scheduled...